Report cover image

Global Radiotracer Preclinical CRO Services Market Growth (Status and Outlook) 2025-2031

Published Aug 06, 2025
Length 109 Pages
SKU # LPI20281279

Description

According to this study, the global Radiotracer Preclinical CRO Services market size will reach US$ 2151 million by 2031.

Radiotracer preclinical CRO services refer to a series of evaluation and research services provided by professional contract research organizations when radioactive imaging probes (such as PET/SPECT tracers) enter the preclinical stage. The service includes radiolabeling process development of tracers, in vivo distribution and metabolism studies (pharmacokinetics), target specificity verification, animal imaging experiments (such as small animal PET/CT), toxicology and dose assessment, etc. It is widely used in the fields of tumors, nervous system, cardiovascular, etc., helping customers to systematically evaluate the performance and safety of radiopharmaceutical imaging and accelerate entry into the clinical trial stage.

United States market for Radiotracer Preclinical CRO Services is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Radiotracer Preclinical CRO Services is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Radiotracer Preclinical CRO Services is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Radiotracer Preclinical CRO Services players cover Charles River, Novotech, Oncodesign Services, Aixial, ABX - CRO, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Radiotracer Preclinical CRO Services Industry Forecast” looks at past sales and reviews total world Radiotracer Preclinical CRO Services sales in 2024, providing a comprehensive analysis by region and market sector of projected Radiotracer Preclinical CRO Services sales for 2025 through 2031. With Radiotracer Preclinical CRO Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Radiotracer Preclinical CRO Services industry.

This Insight Report provides a comprehensive analysis of the global Radiotracer Preclinical CRO Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Radiotracer Preclinical CRO Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Radiotracer Preclinical CRO Services market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Radiotracer Preclinical CRO Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Radiotracer Preclinical CRO Services.

This report presents a comprehensive overview, market shares, and growth opportunities of Radiotracer Preclinical CRO Services market by product type, application, key players and key regions and countries.

Segmentation by Type:
PET Radiotracer
SPECT Radiotracer

Segmentation by Application:
Pharmaceutical Companies
Biotech Companies
Government Agencies
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Charles River
Novotech
Oncodesign Services
Aixial
ABX - CRO
CMIC
Medpace
Minerva Imaging
Chelatec
Konica Minolta
MITRO Biotech
C-Ray
InnoStar Bio-tech

Please note: The report will take approximately 2 business days to prepare and deliver.

Table of Contents

109 Pages
*This is a tentative TOC and the final deliverable is subject to change.*
1 Scope of the Report
2 Executive Summary
3 Radiotracer Preclinical CRO Services Market Size by Player
4 Radiotracer Preclinical CRO Services by Region
5 Americas
6 APAC
7 Europe
8 Middle East & Africa
9 Market Drivers, Challenges and Trends
10 Global Radiotracer Preclinical CRO Services Market Forecast
11 Key Players Analysis
12 Research Findings and Conclusion
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.